Second Generation BTK Inhibitors Impair the Anti-Fungal Response of Macrophages and Neutrophils From CLL Patients

American Journal of Hematology - United States
doi 10.1002/ajh.25816
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Wiley

Related search

Second Cancer Incidence in CLL Patients Receiving BTK Inhibitors

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Acalabrutinib (ACP-196): A Selective Second-Generation BTK Inhibitor

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2016English

Toward Second-Generation Cardiomyogenic and Anti-Cardiofibrotic 1,4-Dihydropyridine-Class TGFβ Inhibitors

ChemMedChem
Organic ChemistryMolecular MedicinePharmacologyBiochemistryToxicologyDrug DiscoveryPharmaceutics
2019English

BTK Inhibitor Ibrutinib in CLL and Mantle Cell Lymphoma

Community Oncology
2013English

Front Cover: Toward Second‐Generation Cardiomyogenic and Anti‐cardiofibrotic 1,4‐Dihydropyridine‐Class TGFβ Inhibitors (ChemMedChem 8/2019)

ChemMedChem
Organic ChemistryMolecular MedicinePharmacologyBiochemistryToxicologyDrug DiscoveryPharmaceutics
2019English

Cell Line‐based Assessment of BTK Inhibitors

British Journal of Pharmacology
Pharmacology
2020English

Origins of Tumor-Associated Macrophages and Neutrophils

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2012English

Neutrophils and Macrophages: The Main Partners of Phagocyte Cell Systems

Frontiers in Immunology
AllergyImmunology
2012English

IFN-γ and IL-17A Differentially Influence the Response of Human Macrophages and Neutrophils to Pseudomonas Aeruginosa Infection.

Infection and Immunity
ParasitologyInfectious DiseasesImmunologyMicrobiology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy